The Food and Drug Administration, responding to the surge in underage vaping, on Wednesday issued a much-anticipated policy designed to make it harder for young people to acquire many types of e-cigarettes.
Outgoing FDA Commissioner Scott Gottlieb rolls out policy to make it harder for minors to get access to certain vaping products. By Laurie McGinley Laurie McGinley Reporter covering health and medicine Email Bio Follow March 13 at 9:47 AM The Food and Drug Administration issued a much-anticipated policy on Wednesday designed to restrict how and where flavored e-cigarettes are sold – an effort to combat what the agency’s commissioner has called “an epidemic” of underage vaping.
Gottlieb also moved up by one year the deadline for flavored e-cigarettes to get agency approval -- to August 2021. The sales restrictions and new deadline would apply to a vast array of e-cigarette products, including those offered in flavors such as cherry and bubblegum. The guidance also bans flavored cigars that were on the market as of 2016 -- although that is a small subset of the total number of flavored cigars on the market.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionThe green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades.
Read more »
FDA moves on vaping, drugs and food at risk with chief’s departureFDA Commissioner Scott Gottlieb was an outlier in the Trump administration, with an activist agenda touching everything from medical device regulation to youth smoking. His departure puts it all in jeopardy
Read more »
FDA approves new generic valsartan to make up for drug shortageThe US Food and Drug Administration approved a new generic of valsartan to help relieve the recent shortage of the medicine, which is used to treat high blood pressure
Read more »
After months of heart drug shortages, FDA approves generic valsartanThe drug's approval was made a priority to help relieve shortages caused by multiple recalls over contamination.
Read more »
Kind bars wants the FDA to change how it regulates food labelsKind, the maker of the popular nut bars, filed a petition Wednesday asking the FDA to change how it regulates claims on food labels.
Read more »
FDA allows treatment of depression with club drug's cousinWASHINGTON (AP) — A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness.
Read more »
Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
Read more »
FDA finds asbestos in makeup at Claire'sThe U.S. Food and Drug Administration on Tuesday warned consumers not to use certain cosmetic products sold by Claire's after they were found to contain asbestos, a known carcinogen. Samples of Claire's eye shadows batch no./lot no. 08/17, compact powder batch no./lot no. 07/15 and contour palette
Read more »
Biotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Read more »